IP Library Granted Patent US 7,252,839
Granted Patent B2
US 7,252,839 · App. 10/528,237 · Granted Aug 7, 2007

Delivery system and a manufacturing process of a delivery system

Assignee: Schering Oy
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,252,839
App. No.
10/528,237
Granted
Aug 7, 2007
Kind
B2
Abstract

A delivery system including a body construction ( 7 ) and at least one capsule ( 8 ) containing a pharmaceutical composition, the capsule having at least a first end and a second end. The body construction ( 7, 12, 34 ) has at least two locking parts ( 9, 10 ), each locking part ( 9, 10 ) having at least a first end and a second end, the first end of each locking part ( 9, 10 ) having a surface adapted to face and cover one of the at least first and second ends of the capsule ( 8 ). The diameter of at least one of the locking parts varies along its length between the first end and the second end, and the capsule ( 8 ) is mounted between the at least two locking parts. Also disclosed is a manufacturing process of a delivery system, the system including a body construction and at least one capsule containing a pharmaceutical composition.

Claims (12)

1. A delivery system comprising a body construction and at least one capsule containing a pharmaceutical composition, said capsule having at least a first end and a second end, wherein the body construction has at least two locking parts, each locking part having at least a first end and a second end, said first end of each locking part having a surface adapted to face and cover one of the at least first and second ends of the capsule, the diameter of at least one of the locking parts varying along its length between said first end and said second end, and wherein the capsule is mounted between said at least two locking parts, and wherein said locking parts have the shape of a truncated cone, wherein said capsule containing a pharmaceutical composition consists essentially of a biocompatible polymer and at least one pharmaceutically active agent.

2. The system of claim 1 , wherein the cross-sectional profile of said at least first or second end of the capsule is essentially identical in size and shape to said surface of the locking part facing said end of the capsule.

3. The system of claim 1 , wherein said body construction consists of one body part.

4. The system of claim 1 , wherein said body construction consists of at least two body parts.

5. The system of claim 1 , wherein the end of the truncated cone having a larger diameter is the end having the said surface facing said end of the capsule.

6. The system of claim 1 , wherein the surface of the cross-section of said at least first or second end of the capsule is essentially smaller than said surface of the locking part facing said end.

7. The system of claim 1 , wherein it has two or more capsules containing a pharmaceutical composition.

8. The system of claim 1 , wherein said system is an intrauterine system.

9. A manufacturing process for a delivery system, said system comprising a body construction and at least one capsule containing a pharmaceutical composition, comprising

injection molding said body construction, and then

injection molding said capsule onto said construction body in a separate step, wherein said capsule has at least a first end and a second end, wherein the body construction has at least two locking parts, each locking part having at least a first end and a second end, said first end of each locking part having a surface adapted to face and cover one of the at least first and second ends of the capsule, the diameter of at least one of the locking parts varying along its length between said first end and said second end, wherein the capsule is mounted between said at least two locking parts, and wherein said locking parts have the shape of a truncated cone, wherein said capsule containing a pharmaceutical composition consists essentially of a biocompatible polymer and at least one pharmaceutically active agent.

10. The process of claim 9 , wherein said body construction consists of one body part.

Assignments (3)
CHANGE OF NAME Recorded Oct 3, 2016
From: SCHERING OY
To: BAYER SCHERING OY
Reel/Frame 040206/0336 →
CHANGE OF NAME Recorded Oct 3, 2016
From: BAYER SCHERING OY
To: BAYER OY
Reel/Frame 040206/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2005
From: HALLINEN, ESA; LYYTIKAINEN, HEIKKI; JARVELA, PENTTI; KIVI, ILKKA
To: SCHERING OY
Reel/Frame 017292/0986 →
Priority Claims (1)
EP 02020869 · Sep 18, 2002 · regional
Continuity (1)
Related Publication 20060016451A1 · Jan 26, 2006